Navigation Links
Rady Venture Fund Develops Next Generation Tech Investors
Date:3/20/2013

SAN DIEGO, March 20, 2013 /PRNewswire-USNewswire/ -- The Rady School of Management's student-run venture capital fund, the Rady Venture Fund, has participated in a $16 million Series B raise in startup Savara Pharmaceuticals, which is developing an inhalable antibiotic to treat cystic fibrosis patients with lung infections. The Rady Venture Fund's investment in Savara was made in conjunction with an investment by the Tech Coast Angels, the largest and most active angel investor network in the U.S. The investment provided Rady MBA students invaluable, hands-on investment experience in deploying investment capital to support emerging companies.

"Unique to MBA schools, the Rady Venture Fund was started to support the Rady School's educational objectives in the areas of entrepreneurship, innovation and translation of discoveries into the marketplace," said Lada Rasochova, Director, California Institute for Innovation and Development and Managing Director, Rady Venture Fund. "Students take a series of courses in new venture finance and venture capital management where they gain hands-on experience in conducting due diligence and making investment decisions. Each investment is reviewed and approved by an investment committee of experienced venture capitalists and includes at least one independent external investor."

"The Rady Venture Fund students are instrumental in the process of identifying and evaluating investment opportunities, such as Savara," said Sergio Gurrieri , investor and business advisor at Tech Coast Angels. "Their diverse backgrounds contribute a wealth of experience and industry knowledge to ensure investments are technically and fiscally sound." 

"We are delighted to be a small part of the Rady vision to provide hands on experience to the Rady MBA students," said Rob Neville CEO of Savara Pharmaceuticals. "Industry leaders participated alongside students in a real deployment of investment capital, providing an excellent teaching opportunity. Savara has greatly benefited from the experience as well as access to the Rady network."

Rady student George Smith (MBA '13), a pharmaceutical scientist, explained that his work with the Rady Venture Fund fostered his exploration of a new career path. "As a Ph.D. scientist, who has been in drug discovery for a while, I wanted to expand my business skills and potentially start a company of my own," Smith said. "With this unique experience I have a much better grasp of how to seek initial startup funding and later, how to secure venture capital funding."

For Rady Alumnus Niall O'Donnell (MBA '06), a RiverVest Venture Partners principal, Rady Venture Fund life sciences investment committee member and advisor, the opportunity to mentor Rady Venture students was a rewarding experience. "The venture capital model is changing and the experience that the Rady Venture Fund provides students is a tremendous benefit to them and the region's emerging growth companies," O'Donnell said.

About the Rady School of Management at UC San Diego
The Rady School of Management at UC San Diego is a business school at the confluence of business, science and technology. Our MBA program encourages students to be visionaries who pursue the extraordinary, incubate new ideas, reinvent existing businesses and establish new companies. To find out more about the Rady School visit www.rady.ucsd.edu.


'/>"/>
SOURCE Rady School of Management
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Files Defamation Lawsuit
2. Zyga Technology Announces $25 Million Venture Financing
3. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
4. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
5. InnoPharma Inc. Raises $8 Million in Venture Debt
6. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
7. Pappas Ventures Names Pat Gage to Scientific Advisory Board
8. SJF Ventures Completes Oversubscribed Series A Round for BioSurplus
9. Sunpeaks Ventures Announces Second Quarter 2012 Results
10. Healthcare Expense Management Leader Patientco Receives $3.75M in funding led by BlueCross BlueShield Venture Partners and Sandbox Industries
11. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):